Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-04-11)Premium Content

Mylan Inc (MYL)

2014-04-18@20:45:00 ET
(PRN)

2014-04-17@09:34:32 ET
Potential Mylan Laboratories (MYL) Trade Has 6.88% Downside Protection (FBM)

2014-04-17@06:33:18 ET
Form 4: Update Filing for Mylan Inc (MYL) (VKR)

2014-04-17@05:20:12 ET
Form 144: Filing to Sell 75000 Shares of Mylan Inc (MYL) (VKR)

2014-04-17@05:02:53 ET
Form 144: Filing to Sell 75000 Shares of Mylan Inc (MYL) (VKR)

2014-04-16@16:13:00 ET
(PRN)

2014-04-16@13:28:24 ET
Shares of Mylan Receive a Boost, Up 2.1% (F77)

2014-04-16@10:25:02 ET
Mylan Laboratories (MYL) Showing Resistance Near $48.48 (FBM)

2014-04-16@05:38:59 ET
Form 3: Initial Filing for Mylan Inc (MYL) (VKR)

2014-04-15@13:30:09 ET
Mylan (MYL) Approaches New Downside Target of $44.40 (F79)

2014-04-15@12:46:22 ET
Mylan (MYL) Crosses Pivot Point Support at $45.22 (PSM)

2014-04-15@11:09:35 ET
Potential Mylan Laboratories (MYL) Trade Has 6.95% Downside Protection (FBM)

2014-04-15@10:20:00 ET
(PRN)

2014-04-15@10:08:00 ET
(PRN)

2014-04-15@08:02:22 ET
Prosonix and Mylan Enter Into Global Licensing Agreement for Generic Versions of Inhaled Respiratory Products Flixotide(R) and Flovent(R) (EUR)

2014-04-15@08:00:00 ET
(PRN)

2014-04-15@08:00:00 ET
(PRN)

2014-04-15@08:00:00 ET
Legal Updates, Stock Price Movements, New Awareness Campaigns, and Senior-level Appointments - Analyst Notes on Mylan, WellPoint, Forest, Novatis and Intercept (PRN)